[Skip to Content]
[Skip to Content Landing]
September 5, 2017

Management of Parkinson Disease in 2017: Personalized Approaches for Patient-Specific Needs

Author Affiliations
  • 1Departments of Neurology and Neurosurgery, University of Florida Center for Movement Disorders and Neurorestoration, Gainesville
JAMA. 2017;318(9):791-792. doi:10.1001/jama.2017.7914

Parkinson disease (PD) has been described as one of the most complex syndromes encountered in clinical medicine. Long-term treatment with dopaminergic agents, the mainstay of therapy, necessitates constant recalibration and possibly additional pharmacological, behavioral, and surgical therapy. Numerous motor and nonmotor PD symptoms may complicate the diagnosis and present therapeutic challenges (Figure).